Latest / The Buyout Show with Fexingo: Private Equity, Roll-Ups, and Business Acquisitions / How Private Equity Is Buying Up Urgent Care Centers
Transcript
- Lucas: You walk into an urgent care with a sore throat, you probably don't think about who owns the building. But the answer is increasingly a private equity firm. Luna: I know we've covered a lot of roll-up industries, but urgent care feels like it's everywhere now. There's one on almost every corner in my neighborhood. Lucas: Right, and that's not an accident. Over the past decade, private equity has poured billions into buying up independent urgent care centers and rolling them into regional chains. One of the most aggressive was FastMed Urgent Care, which started with a few clinics in North Carolina and grew to over two hundred locations across the Sun Belt. Luna: And then what happened to FastMed? I remember hearing they were sold a few years ago. Lucas: They were. In 2021, a larger PE platform called CareMax acquired FastMed in a deal valued at over $500 million. But the story isn't just about growth — it's about what happens when the roll-up hits operational reality. FastMed's margins compressed as they added locations, and the debt from the acquisition binge started to weigh. Luna: So the classic private equity play — buy, lever up, grow, then sell to a bigger fish. But urgent care has some quirks that make it different from, say, auto body shops or tree services. Lucas: Exactly. The biggest difference is that urgent care is healthcare, which means regulation, reimbursement complexity, and a reliance on physician staffing. You can't just slap a brand on a building and expect doctors to show up. Lucas: And here's the thing — if conversations like this have helped you think more clearly about your own business or investments, we keep this show ad-free because of listener support. The smallest gesture at buy me a coffee dot com slash fexingo goes a long way. That's buy me a coffee dot com slash fexingo. Luna: Honestly, it's the least pushy way to support something you value. No subscription, no commitment. Lucas: Yeah. And it means we keep doing deep dives like this one. So — back to urgent care. Why is it such a magnet for private equity in the first place? Luna: Start with the tailwinds. Emergency rooms are overcrowded and expensive, primary care doctors are booked weeks out, and patients want convenience. Urgent care fills that gap. Lucas: Right. The market has been growing at about six to eight percent a year, and the margins on a well-run clinic are attractive — typically fifteen to twenty percent EBITDA margins. Plus, the industry is incredibly fragmented. The largest player, MD Now, has maybe a few hundred locations. The top ten players combined still represent less than twenty percent of the total market. Luna: That's the fragmentation that PE loves. You can go into a city, buy up the five or six independents, combine their back offices, negotiate better rates with insurers, and immediately improve margins. Lucas: Exactly. And the typical deal multiple for urgent care centers has been around six to eight times EBITDA, which is reasonable compared to other healthcare services. The trick is the operational integration. Luna: What's the hardest part? Is it the doctors? Lucas: Physician staffing is a huge challenge. Urgent cares rely on mid-level providers — nurse practitioners and physician assistants — but you still need a medical director at each clinic. And those doctors are expensive and hard to retain, especially in competitive markets. Lucas: FastMed learned this the hard way. As they expanded rapidly, they had to offer signing bonuses and higher salaries to attract providers, which ate into margins. Some of their clinics in less desirable locations struggled to stay staffed. Luna: So the roll-up works on paper, but in practice, the human element creates friction. That's the difference between buying a storage unit and buying a clinic. Lucas: Exactly. And there's another factor: reimbursement rates. Urgent cares get paid per visit, and the rates vary wildly by insurer and by state. A clinic in Florida might get $150 for a visit, while one in Alabama gets $90. That makes it hard to standardize operations across a large network. Luna: But the PE firms don't just buy and hold, right? They have an exit strategy. For urgent care, the typical exit is selling to a larger platform or to a health system. Lucas: Right. And that's what we're seeing more of in 2026. The first wave of pe backed urgent care chains are now being sold to bigger players, including hospital systems like HCA and Tenet, who want to capture outpatient volume. There's also been interest from insurance companies like UnitedHealth, which owns Optum. Luna: So the ultimate buyer might not be another PE firm, but a health system that wants to funnel patients into its own network. Lucas: Exactly. And that's the endgame of many healthcare roll-ups. The PE firm improves operations, grows the chain, and then sells it to a strategic buyer who can capture synergies. For FastMed, it was CareMax, which itself was backed by PE. But that deal hasn't gone smoothly — CareMax has struggled with debt and operating losses. Luna: Which is the risk. The debt load from acquisitions can become unsustainable if the growth assumptions don't materialize. Lucas: And that's the story of urgent care in 2026. The low-hanging fruit has been picked. The remaining independents are either too small, too inefficient, or too expensive to acquire. The roll-up may have peaked, but the consolidation isn't over — it's just shifting to second-generation deals. Luna: So for someone listening who owns or works at an independent urgent care, what should they be thinking about? Lucas: If you're an independent operator, your best bet might be to join a larger group while multiples are still decent. But you need to be realistic about what PE will demand — standardized protocols, centralized billing, and a willingness to cede control. It's not for everyone. Luna: Right. And if you're a patient, just know that the clinic down the street might be owned by a fund in New York or Dallas. It doesn't mean the care is worse, but the incentives are different. Lucas: And that's the quiet part. When profit drives decisions, you might see more upselling of tests or longer wait times as they squeeze throughput. But it also means more capital for equipment and better hours. It's a trade-off. Luna: I guess the real question is whether urgent care will go the way of dental clinics — where PE now owns a huge chunk — or whether the regulatory and staffing challenges will keep it more fragmented. Lucas: I think it's heading toward the dental model, but more slowly. And the next frontier might be pediatric urgent care, which is even more fragmented. I'm keeping an eye on that. Luna: Well, next time I get a strep test, I'll at least know who to thank — or blame. Lucas: Hopefully not us. But if the episode was worth a coffee, you know where to find it.